Merck Serono, Mendor sign blood glucose meter distribution agreement

Published on February 14, 2012 at 5:57 AM · No Comments

Mendor, the Finnish diabetes technology company, continues its rapid growth and is excited to announce yet another international partnership - now opening the United Kingdom for its innovative products. Mendor has just signed a distribution agreement with a leading pharmaceutical company in the Diabetes field Merck Serono, covering the United Kingdom diabetes market.

Mendor's first product, a blood glucose meter the Mendor Discreet™, is a unique device that contains all the necessary components for daily blood glucose measurements: the meter, 25 strips and a lancing device in an integrated, stylish device the size of a mobile phone. Mendor Discreet™ is designed to simplify the lives of people with diabetes who regularly need to test their blood glucose levels.

Mendor and Merck Serono are aiming for a launch in the British market this March at the Diabetes UK exhibition in Glasgow. Healthcare professionals will be able to see first-hand this new easy-to-use, highly portable and integrated device.

This new partnership adds to the list of distribution agreements Mendor has been proud to announce recently, including partnerships with EBN Sina in Qatar and Mediq in the Baltics. With continued expansion on its agenda, Mendor is continuing negotiations with several major international players in the global diabetes market and is looking forward to launching in several new markets during 2012.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment